Rice Hall James & Associates’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.61M | Buy |
1,472,527
+74,470
| +5% | +$284K | 0.3% | 77 |
|
|
2025
Q1 | $3.68M | Buy |
1,398,057
+408,422
| +41% | +$1.07M | 0.22% | 102 |
|
|
2024
Q4 | $3.5M | Buy |
989,635
+367,970
| +59% | +$1.3M | 0.19% | 124 |
|
|
2024
Q3 | $2.83M | Buy |
621,665
+124,438
| +25% | +$567K | 0.15% | 142 |
|
|
2024
Q2 | $2.16M | Buy |
497,227
+216,122
| +77% | +$940K | 0.13% | 156 |
|
|
2024
Q1 | $1.41M | Buy |
281,105
+200,101
| +247% | +$1M | 0.08% | 194 |
|
|
2023
Q4 | $508K | Sell |
81,004
-6,067
| -7% | -$38K | 0.03% | 246 |
|
|
2023
Q3 | $620K | Buy |
87,071
+7,241
| +9% | +$51.6K | 0.04% | 234 |
|
|
2023
Q2 | $813K | Buy |
+79,830
| New | +$813K | 0.05% | 226 |
|